FDA 483 - Louisville APL Diagnostics, Inc. - December 19, 2022

Louisville APL Diagnostics, Inc., a medical device manufacturer in Texas City, TX, was inspected by the FDA from December 14-19, 2022. The inspection revealed significant deficiencies in labeling control, complaint handling procedures, and design validation documentation. These issues indicate a need for improved quality system compliance.